United States · FDA National Drug Code directory
sugammadex
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76045-219_d82ad889-b1e4-4f3e-8767-c8228a00a6a8
- Product NDC
- 76045-219
- Form
- INJECTION, SOLUTION
- Composition / generic term
- sugammadex
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260728
- Source listing expiry
- 20271231
Source-listed ingredients
- SUGAMMADEX SODIUM — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 24 SYRINGE in 1 CARTON (76045-219-20) / 2 mL in 1 SYRINGE (76045-219-02) · 76045-219-20
- 24 SYRINGE in 1 CARTON (76045-219-24) / 2 mL in 1 SYRINGE (76045-219-04) · 76045-219-24
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →